Home > Financial Ratios > MANKIND PHARMA

MANKIND PHARMA
Core EBITDA Margin

    Back to All Ratios
MANKIND PHARMA is part of below Screeners ↓
Top Large Cap Stocks with Best Fundamentals
Best Quarterly Growth Large Cap Stocks
COMMUNITY POLL
for MANKIND PHARMA
Please provide your vote to see the results

MANKIND PHARMA Last 5 Year Core EBITDA Margin History

[Consolidated]

Mar2023Mar2022Mar2021Mar2020Mar2019
   Core EBITDA Margin(%) 20.8924.6625.5023.6818.57

What is the latest Core EBITDA Margin ratio of MANKIND PHARMA ?

The latest Core EBITDA Margin ratio of MANKIND PHARMA is 20.89 based on Mar2023 Consolidated results.
Year Core EBITDA Margin
Mar202320.89
Mar202224.66
Mar202125.50
Mar202023.68
Mar201918.57

How is Core EBITDA Margin of MANKIND PHARMA Trending?

Years Core EBITDA Margin % Change
Mar2023 20.89
-15.29
Mar2022 24.66
-3.29
Mar2021 25.5
7.69
Mar2020 23.68
27.52
Mar2019 18.57 -

Other Financial Ratios of MANKIND PHARMA


Compare Core EBITDA Margin ratio of peers of MANKIND PHARMA

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
MANKIND PHARMA ₹85,970.8 Cr 1.5% -8.1% 53.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹350,339.0 Cr -0.5% -3.8% 50.8% Stock Analytics
CIPLA ₹116,930.0 Cr -2% 2% 53.3% Stock Analytics
DIVIS LABORATORIES ₹114,416.0 Cr 1.3% 8.7% 26.8% Stock Analytics
ZYDUS LIFESCIENCES ₹100,694.0 Cr -5.5% 1.3% 99.9% Stock Analytics
DR REDDYS LABORATORIES ₹96,546.9 Cr -1.7% -8% 28.9% Stock Analytics


MANKIND PHARMA Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
MANKIND PHARMA

1.5%

-8.1%

53.1%

SENSEX

-1.9%

-0.7%

18.3%


You may also like the below Video Courses